Literature DB >> 35771426

Immunohistochemistry for VM Markers.

Alessio Biagioni1, Elena Andreucci2.   

Abstract

Vasculogenic mimicry (VM) is the biological process by which aggressive cancer cells are able to organize themselves-independently from endothelial cells-into new vessel-like structures to sustain fast tumor perfusion and thus an efficient supply of oxygen and nutrients, required for rapid cancer growth and dissemination. In the last two decades, the molecular mechanisms and key regulators of VM have been identified. Several methods are currently available to detect VM both in vitro and in vivo, but the gold standard is still the immunohistochemical staining of specific antigens. Even though many markers are debated if belong to the angiogenic process or VM exclusively, the immunohistochemistry of CD31 and the PAS reaction often clarify in frozen or paraffin sections the pathologic status and the vasculature grade of a tumor mass.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; CD31; Immunohistochemistry; PAS reaction; Vasculogenic mimicry

Mesh:

Year:  2022        PMID: 35771426     DOI: 10.1007/978-1-0716-2403-6_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

Authors:  R E Seftor; E A Seftor; N Koshikawa; P S Meltzer; L M Gardner; M Bilban; W G Stetler-Stevenson; V Quaranta; M J Hendrix
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 2.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 3.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

4.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix.

Authors:  Andrew J Maniotis; Xue Chen; Christopher Garcia; Phillip J DeChristopher; Ding Wu; Jacob Pe'er; Robert Folberg
Journal:  Lab Invest       Date:  2002-08       Impact factor: 5.662

6.  Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma.

Authors:  Man Li; Yanjun Gu; Zhiguang Zhang; Shiwu Zhang; Danfang Zhang; Ali F Saleem; Xiulan Zhao; Baocun Sun
Journal:  Pathol Oncol Res       Date:  2009-12-17       Impact factor: 3.201

7.  Prognostic role of vasculogenic mimicry in colorectal cancer.

Authors:  Coen I M Baeten; Femke Hillen; Patrick Pauwels; Adriaan P de Bruine; Cor G M I Baeten
Journal:  Dis Colon Rectum       Date:  2009-12       Impact factor: 4.585

Review 8.  Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Gina C Schatteman; Lynn M Gruman; Angela R Hess; Dawn A Kirschmann; Richard E B Seftor; Mary J C Hendrix
Journal:  Crit Rev Oncol Hematol       Date:  2002-10       Impact factor: 6.312

9.  HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.

Authors:  Jian Yang; Dong-Ming Zhu; Xiao-Gang Zhou; Ni Yin; Yi Zhang; Zi-Xiang Zhang; De-Chun Li; Jian Zhou
Journal:  Oncotarget       Date:  2017-07-18

Review 10.  Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.

Authors:  Xue Zhang; Jigang Zhang; Heming Zhou; Guorong Fan; Qin Li
Journal:  J Cancer       Date:  2019-10-18       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.